Yes, it just needs a smooth and comprehensive release of the DKD into the US market by Sonic and then the share price should reflect the revenue. In that research paper done recently a figure of $78 million(120 Aussie) could be achieved if two million tests are administered a year. This is going to be profound for the company's share price once they get there, though, I'm not sure how long it will take to achieve this figure.
Not sure what the earnings to value ratio if they start bringing that sort of money, but I presume the company will be worth upwards of a billion. Do you know what the ratio might be for med stocks which are getting their revenue from royalties?
Yes, it just needs a smooth and comprehensive release of the DKD...
Add PIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
70.5¢ |
Change
0.010(1.44%) |
Mkt cap ! $92.35M | |||
| Open | High | Low | Value | Volume |
| 71.0¢ | 71.0¢ | 69.0¢ | $10.51K | 14.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 101449 | 69.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 71.0¢ | 10000 | 1 |
View Market Depth
| Last trade - 12.53pm 15/11/2024 (20 minute delay) ? |
| PIQ (ASX) Chart |